The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society

Abstract

Extracorporeal photopheresis (ECP) has been used for over 35 years in the treatment of erythrodermic cutaneous T-cell lymphoma (CTCL) and over 20 years for chronic and acute graft-versus-host disease (GvHD) and solid organ transplant rejection. ECP for CTCL and GvHD is available at specialised centres across the UK. The lack of prospective randomised trials… (More)
DOI: 10.1111/bjh.14537

Topics

5 Figures and Tables

Cite this paper

@inproceedings{Alfred2017TheRO, title={The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society}, author={Arun Alfred and Peter C Taylor and Fiona L Dignan and Khaled El‐Ghariani and James D Griffin and Andrew Gennery and Denise K. Bonney and Emma Das‐Gupta and Sarah E Lawson and Ram Malladi and Kenneth W Douglas and Tracey Maher and Julie Guest and Laura Hartlett and Andrew J. Fisher and Fiona J Child and Julia J. Scarisbrick}, booktitle={British journal of haematology}, year={2017} }